CraveO2: A New Approach to Addiction — Oxygen, the Brain, and the Science of Craving
Addiction is a neurological condition. CraveO2 is LiveO2’s protocol that addresses the brain’s oxygen needs as a component of addiction remediation — a unique and evidence-informed approach.
Who This Is For
This is for people navigating addiction recovery, mental health practitioners, and anyone curious about the neurological and oxygen-related dimensions of craving and addiction.
- People in addiction recovery seeking complementary support approaches
- Mental health and addiction practitioners interested in oxygen therapy as an adjunct
- Individuals experiencing strong cravings who want to understand the neurological basis
- Family members supporting loved ones in addiction recovery
- Healthcare providers exploring non-pharmaceutical supports for addiction treatment
Addiction and the Neurological Oxygen Connection
Addiction is fundamentally a neurological condition: the brain’s reward circuitry, altered by repeated substance exposure, produces craving states that drive compulsive use despite negative consequences. Conventional addiction treatment addresses the behavioral, psychological, and pharmacological dimensions of this neurological disruption — and these approaches have documented value. But they often miss a physiological substrate: the brain’s oxygen needs, and how improved cerebral oxygenation can reduce craving intensity and support neurological recovery.
The neurological tissue disrupted by addiction is metabolically active and oxygen-dependent. Recovery requires not just absence of the substance but actual neurological healing — restoration of receptor function, normalization of neurotransmitter dynamics, and reduction of the neuroinflammation that addiction leaves behind. Oxygen delivery to this healing tissue is not incidental — it is a direct support for the neurological recovery process.
How CraveO2 Addresses Craving Through Oxygen
CraveO2 is LiveO2’s protocol specifically designed for addiction remediation support. It uses the Adaptive Contrast mechanism to improve cerebral blood flow and oxygen delivery to the brain regions most affected by addiction — the prefrontal cortex (executive function and impulse control), the limbic system (reward processing and craving), and the regions supporting emotional regulation. The improved oxygenation supports both the reduction of craving intensity in the short term and the neurological healing that reduces dependence in the long term.
CraveO2 is designed to complement, not replace, established addiction treatment approaches. Used alongside behavioral therapy, support groups, and appropriate medical treatment, it provides the neurological oxygen support that the other modalities cannot directly deliver. The combination typically produces better outcomes than any single approach alone.
What Users Experience
People using CraveO2 as part of addiction recovery report:
- Reduced intensity of craving states — a meaningful change in the subjective experience of withdrawal and recovery
- Improved emotional regulation — less reactivity and greater stability during the early recovery period
- Better sleep quality — which is severely disrupted during addiction recovery and directly affects craving
- Improved cognitive clarity as the prefrontal function that supports decision-making is better oxygenated
- Greater engagement with behavioral therapy and support programs as cognitive and emotional function improve
Key Takeaways
- Addiction recovery has a neurological oxygen component that CraveO2 specifically addresses
- Improved cerebral oxygenation supports the prefrontal and limbic function that craving disrupts
- CraveO2 is an adjunct to — not a replacement for — established addiction treatment approaches
- Neuroinflammation from addiction is reduced by improved cerebral oxygenation
- Better cognitive and emotional function from CraveO2 improves engagement with other recovery modalities
- The brain heals through a physiological process that requires oxygen — CraveO2 supports that process directly
Support your neurological recovery
CraveO2 addresses the brain’s oxygen needs as part of addiction remediation — a physiological support that conventional approaches miss.
Explore LiveO2 Systems Talk to an ExpertFrequently Asked Questions
CraveO2 is not presented as a treatment for addiction — addiction is a complex medical condition requiring professional treatment. CraveO2 is an adjunctive support protocol that addresses the neurological oxygen component of recovery. It is designed to be used alongside established addiction treatment, not in place of it. Always coordinate with your treatment team when adding any new intervention to an addiction recovery program.
The neurological basis of craving involves the limbic system overriding prefrontal cortical control — essentially, the brain’s reward-seeking circuits overwhelming the circuits for deliberate decision-making. Improved cerebral oxygenation through CraveO2 directly supports prefrontal function (executive control and impulse regulation) and reduces the neuroinflammation that amplifies limbic reactivity. The result is a shift in the neurological balance toward greater cognitive control and reduced craving dominance.
The neurological mechanisms that CraveO2 addresses — prefrontal support, limbic regulation, neuroinflammation reduction — are relevant across addiction presentations including alcohol, opioids, stimulants, and behavioral addictions. The specific mechanism is not substance-specific: it addresses the brain state that characterizes addiction regardless of the original substance.
CraveO2 is designed as an adjunct — it provides the neurological oxygen support that other modalities cannot deliver. Combined with behavioral therapy (which addresses psychological and behavioral patterns), medical treatment where appropriate (which addresses physiological dependence), and peer support (which addresses social and identity dimensions), CraveO2 adds the neurological oxygen component to a comprehensive recovery approach.
The main consideration is the exercise component — people in early recovery from severe physical dependence (especially alcohol) may have cardiovascular instability that requires medical clearance before exercising. Once medically stable, the gentle exercise component of CraveO2 is typically appropriate. The oxygen component itself is safe for virtually all presentations. Always coordinate with your treatment team.
Craving reduction from improved cerebral oxygenation can often be noticed within the first few sessions — a reduction in the intensity of craving states following sessions. More sustained improvement in emotional regulation and cognitive function typically develops over 2–4 weeks of consistent use. The longer-term neurological recovery that reduces baseline craving reflects months of consistent use.